RevealDx
-
Business & Markets · Enterprise RevealDx Announces Distribution Agreement And Investment From 4DMedical
Insider Brief PRESS RELEASE — RevealDx, a leader in AI characterization of lung nodules, announced today, following World Lung Cancer Day, a distribution agreement and strategic investment of $3.4 million by 4DMedical (ASX: 4DX), expanding access to its flagship product, RevealAI-Lung.… -
Business & Markets · Enterprise RevealDx Receives FDA Clearance for AI Powered Lung Nodule Risk Assessment
The AI economy, every weekday morning
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.